More effective and less resistance-prone antiviral agents are now available to treat hepatitis
B virus (HBV) infection. Profound, durable, therapeutic HBV DNA suppression to slow and …

Large amounts of new data on the natural history and treatment of chronic hepatitis B virus
(HBV) infection have become available since 2005. These include long-term follow-up …

Entecavir is a potent antiviral agent with high genetic barrier to resistance, hence it is
currently recommended as first‐line antiviral therapy for chronic hepatitis B (CHB). The aim …

These guidelines have been written to assist physicians and other health care providers in
the recognition, diagnosis, and management of patients chronically infected with the …

Background Current treatments for chronic hepatitis B are suboptimal. In the search for
improved therapies, we compared the efficacy and safety of pegylated interferon alfa plus …

Reactivation of hepatitis B refers to the abrupt increase in hepatitis B virus (HBV) replication
in a patient with inactive or resolved hepatitis B. Reactivation can occur spontaneously, but …

Purpose Reactivation of hepatitis B virus (HBV) infection is a well-recognized complication
in cancer patients with chronic HBV (hepatitis B surface antigen [HBsAg] positive) …

Background Reducing hepatitis B virus (HBV) replication to minimal levels is emerging as a
key therapeutic goal for chronic hepatitis B. Methods In this double-blind, phase 3 trial, 1370 …

LU Feng-min and ZHUANG Hui epatitis B virus (HBV) infection is a global public health
problem. According to the data of World Health Organization (WHO), 2 billion people …

Background & Aims: There is a paucity of data on hepatitis B virus (HBV) DNA levels and
histologic lesions in patients with chronic HBV (CHBV) infection and persistently normal …